Results - Announcements
Kopran Ltd share price ticked higher by 1.17% to Rs 242.1 after the company's net profit plunged by 34.48% to Rs 4.39 crore, while revenue from operations gained significantly 37.19% to Rs 211.26 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.72 lakh crore, rising 5.09%. It has marginally improved by 2.16% over last one week and moved up slightly by 0.86% in last one month while the market capitalization of Kopran Ltd has softened by 3.04% and 23.72% in the same period respectively.
Profit before tax (PBT) of Kopran Ltd stood at Rs 5.89 crore in Q3 FY26, nosediving by 150.64% year-on-year, and crashing by 33.07% quarter-on-quarter. EBITDA came in at Rs 15 crore, plunging by 378.53% YoY and easing 7.56% sequentially.
Total expenses witnessed a sharp rise of 40.14% to Rs 201.74 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 136.03 crore, advancing by 12.52% YoY, while employee benefits expense was at Rs 20.18 crore, registering a growth of 9.32% YoY.
For the TTM ended FY26, revenue from operations grew marginally by 8.23% to Rs 681.42 crore, while net profit tumbled by 33.26% to Rs 25.73 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 6980% to Rs 61.6 crore, and PBT tanked by 33.86% to Rs 34.36 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 66.75 crore in FY26, as against Rs 41.94 crore in FY25.
Kopran Ltd rallied 46.02% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 9.87% during the same period.